Introduction
============

Associations between insufficient or excessive gestational weight gain (GWG) and short and long term maternal and child health outcomes are well described.[@ref1] Insufficient weight gain has been linked with increased risks of low birth weight, small for gestational age, and preterm birth, while excessive gain has been associated with large for gestational age, gestational diabetes, preterm birth, caesarean section, infant mortality, postpartum weight retention, and childhood obesity.[@ref2] [@ref3] [@ref4] [@ref5] [@ref6] [@ref7] [@ref8] [@ref9] Pregnant women are therefore routinely weighed in clinical settings. The benefits of doing so, however, are debatable in the absence of appropriate guidelines or even agreement on what constitutes adequate weight gain.[@ref10] [@ref11]

In 1970, the Institute of Medicine/National Research Council reviewed the available evidence on GWG that resulted in good pregnancy outcomes, with subsequent revisions in 1990 and 2009.[@ref1] [@ref12] [@ref13] The latest guidelines evaluated the trade offs between maternal and child health outcomes and weight gain during pregnancy, including the risks of small for gestational age and preterm birth with inadequate GWG and the increased rates of caesarean section and postpartum weight retention with excessive GWG. Based on a recent systematic review, however, these guidelines were all derived from country specific studies that varied in sample selection, study design, and methods of data collection and statistical analysis.[@ref14] In the United Kingdom, "routine weighing during pregnancy should be confined to circumstances in which clinical management is likely to be influenced."[@ref15] In countries where routine weighing is recommended, most current guidelines are based on relating observed GWG to pregnancy outcomes and then determining the range of weight gain with the lowest perinatal risk,[@ref1] [@ref16] [@ref17] [@ref18] although other authors have attempted to select populations with good perinatal outcomes and then retrospectively determine the associated GWG range.[@ref19] [@ref20] [@ref21] [@ref22]

The World Health Organization recommends that a reference for GWG be based on prospective longitudinal studies of selected populations with a low incidence of maternal and fetal complications, where anthropometric measures are collected before and during pregnancy and postpartum.[@ref23] The same "prescriptive" approach was adopted by WHO in producing international growth standards for children aged 0-5 years that have now been adopted by more than 125 countries worldwide,[@ref24] and by the International Fetal and Newborn Growth (INTERGROWTH-21^st^) Consortium for the 21^st^Century in producing standards for early pregnancy dating,[@ref25] fetal growth,[@ref26] newborn size,[@ref27] and postnatal growth for preterm infants.[@ref28] We examined data on GWG obtained, according to WHO recommendations, from healthy pregnant women who were free from identifiable major medical, nutritional, or social and major environmental risk factors.[@ref26] [@ref29] [@ref30] The women had pregnancies with good maternal and perinatal outcomes.[@ref31] Based on these data, we report GWG patterns from normal weight women.

Methods
=======

Study site and population selection
-----------------------------------

INTERGROWTH-21^st^ was a multicentre multiethnic population based project conducted between April 2009 and March 2014 in eight well defined urban sites: Pelotas (Brazil), Turin (Italy), Muscat (Oman), Oxford (UK), Seattle (US), Shunyi County in Beijing (China), the central area of Nagpur (India), and the Parklands suburb of Nairobi (Kenya). The primary aim was to produce international standards for fetal, newborn, and preterm growth using the same conceptual framework as the WHO Multicentre Growth Reference Study[@ref24] [@ref30] [@ref32] to complement the existing WHO Child Growth Standards.

We recruited women who started antenatal care before 14 weeks' gestation with reliable menstrual dates and a confirmatory ultrasound dating scan who met the entry criteria of optimal health, nutrition, education, and socioeconomic status and were not exposed during pregnancy to environmental hazards.[@ref25] [@ref29] [@ref30] These low risk women constituted the population of the Fetal Growth Longitudinal Study (FGLS) component of the INTERGROWTH-21^st^ Project.[@ref26]

Measurements
------------

A detailed manual with instructions for all adult measurement techniques, the methods for multicentre standardisation of those measures, and the procedures for the calibration and maintenance of equipment have been published elsewhere.[@ref33] [@ref34] [@ref35] All documentation, protocols, data collection forms, and electronic transfer strategies are available at [www.intergrowth21.org](http://www.intergrowth21.org). Briefly, the women's height and weight were measured in duplicate with a Seca 264 stadiometer and Seca 877 scale (Seca, Germany), respectively, on study entry between 9 and 13^+6^ weeks' gestation. A first trimester body mass index (BMI) was calculated and categorised as normal weight (18.50-24.99) or overweight (25.00-29.99), according to the WHO definition.[@ref36] The same standardised methods and clinical procedures were used to measure maternal weight every five weeks (plus/minus one week) until delivery, so that the possible ranges after recruitment in which weight was measured were 14-18, 19-23, 24-28, 29-33, 34-38, and 39-42 weeks' gestation.[@ref35]

Statistical analyses
--------------------

GWG was calculated as the measured weight at each antenatal visit minus the measured weight in the first trimester. According to prespecified criteria, we excluded pregnancies complicated by fetal death or congenital abnormality, catastrophic or severe medical conditions (such as cancer or HIV), those with severe unanticipated conditions related to pregnancy that required admission to hospital (such as eclampsia or severe pre-eclampsia), and those identified during the study who no longer fulfilled the entry criteria (such as women who started smoking during pregnancy or had an episode of malaria).

The first step was to assess variation in GWG across sites and whether we could pool the data. A detailed analysis of the methods used to assess the similarity of fetal and newborn data from all eight INTERGROWTH-21^st^ sites to permit pooling has been reported elsewhere.[@ref31] [@ref37] We applied the same methods to the GWG data by using variance component analysis (analysis of variance (ANOVA)) to calculate the percentage of variance in the longitudinal weight measurements from variance between sites adjusted for gestational age (fixed effects) while sites and individuals were treated as random effects, and a standardised site difference (SSD), similar to a z score, calculated as the difference between the mean of one site and the mean of all sites together. Each difference was then expressed as a proportion of the all sites' standard deviation (SD) (that is, SD of the data pooled across all sites) at each corresponding gestational age. The SSD allows for direct comparisons across gestational age windows, and we prespecified a value of ≤0.5 as adequate for combining data from all sites. This is similar to the cut off used in the WHO Multicentre Growth Reference Study to create international standards for infant and child growth.[@ref38]

In a second step we constructed smoothed centiles of GWG according to gestational age. The statistical methods we used were informed by the recommendations of Altman and Royston[@ref39] [@ref40] and recent literature reviews.[@ref41] [@ref42]

We applied a multilevel linear regression analysis accounting for repeated measures, adjusting for gestational age, which we treated as a fixed effect, whereas sites and individuals were treated as random effects.[@ref38] As weight gain exhibited a non-normal distribution, we log transformed (natural log) data to stabilise variance and transform the data to normality. We added a constant 8.5 for normal weight women to all values to shift the minimum value of the distribution to 1 to ensure no negative values when we modelled on the log scale. The best fitting powers for the mean weight gain were provided by second degree fractional polynomials and further modelled in a multilevel framework to account for the longitudinal design of the study (repeated measures). The data structure comprises two levels---that is, measurements within and between women. Therefore, we fitted a random effects model (two level hierarchical structure) to the longitudinal GWG measurements as a function of gestational age using the *runmlwin* package in STATA.[@ref43] To obtain an equation for the SD, we modelled the resulting variance components from the multilevel model that accounts for the correlations between and within women using fractional polynomials. The SD was modelled on the log scale to stabilise variance. Assessment of goodness of fit incorporated a visual inspection of the overall model fit by comparing empirical centiles (calculated per completed week of gestation---for example, 38 weeks' gestation=38-38^+6^ weeks' gestation) to the fitted centiles; a quantile-quantile (q-q) plot of the residuals; and a plot of fitted z scores across gestational ages.

As the first weight measurement was taken between 9 and 13^+6^ weeks' gestation, we performed a sensitivity analysis to explore the likelihood of potential bias that might arise as a result of this classification. Based on a reported range in weight gain of 0.5-2 kg in the first trimester,[@ref1] we performed a post hoc analysis to estimate the proportion of women who were within 2 kg of the lower limit in the normal weight group (and so could have been underweight before conception) and, similarly, those within 2 kg of the lower cut off for overweight women, as they might actually have been normal weight before conception. The data were modelled with the same analytical strategy and the resultant centiles compared with those obtained from our original classification of normal weight (that is, based on the first trimester BMI). All analyses were performed in STATA, version 11.2, software (StataCorp LP, College Station, TX, US). Furthermore, to rule out potential bias from caesarean section, we performed a sensitivity analysis excluding all births by caesarean section and refitting the final model to the remaining data and compared this with the model using all the data.

Patient involvement
-------------------

No patients were involved in setting the research question or the outcome measures, nor were they involved in the design and implementation of the study. There are no plans to involve patients in dissemination.

Results
=======

A total of 13 108 pregnant women at \<14 weeks' gestation were screened (fig 1[](#f1){ref-type="fig"}), and 4607 met the eligibility criteria, provided consent, and were enrolled in the Fetal Growth Longitudinal Study. The contribution from each site to the total enrolled sample population ranged from 311 (7%) for the US to 640 (14%) for the UK.

![**Fig 1** Flowchart for selecting women included in study of gestational weight gain](chel028538.f1_default){#f1}

The most common reasons for ineligibility were maternal height \<153 cm (1022/8501; 12%), BMI ≥30 (1009/8501; 12%), and age \<18 or \>35 years (915/8501; 11%) at screening. During the pregnancy, 71 women were lost to follow-up or withdrew consent and 36 were excluded (during pregnancy 29 had severe medical conditions, six took up smoking, and one used recreational drugs). After exclusion of 78 miscarriages, terminations, or stillbirths, there were 4422 live singleton births of which a further 101 were excluded because of congenital malformations. Of the 4321 remaining women, eight were excluded from the analysis (four with only one weight measurement during pregnancy and four who were obvious outliers because of illogical values that could not be corrected during data cleaning). We excluded nine observations with extreme weight changes (defined as a gain or loss of \>5 kg/week).

Our final sample therefore consisted of 4313 women who contributed 24 977 weight measurements. Of these, 3097 (72%) women had normal weight in the first trimester. Here we report the analyses pertaining to these normal weight women whose data were used to construct the international GWG standard.

The demographic characteristics of the study cohort were similar across the eight sites and have been reported elsewhere.[@ref31] Women had a median of six weight measurements (range 2-7); median gestational age at first antenatal visit was 11.9 weeks (SD 1.4 weeks); mean maternal age was 28.2 (SD 3.8) years; 97% (3020/3097) were married or living with a partner, and 72% (2230/3097) were nulliparous. Table 1[](#tbl1){ref-type="table"} shows sociodemographic information and pregnancy and perinatal events. Fig 2[](#f2){ref-type="fig"} shows an example of the crude weight gain trajectories of a simple random sample of 100 normal weight women, illustrating the longitudinal design of the study.

###### 

Baseline characteristics and pregnancy outcomes of the normal-weight women. Values are mean (SD) for continuous variables, and number (percentage) for categorical variables

                                                             Normal BMI (n=3097)
  ---------------------------------------------------------- ---------------------
  Parents                                                    
  Maternal age (years) (SD)                                  28.2 (3.8)
  Maternal height (cm) (SD)                                  162.3 (5.9)
  Maternal weight (kg) (SD)                                  57.2 (6.5)
  Paternal height (cm) (SD)                                  174.2 (7.3)
  Body mass index (SD)                                       21.7 (1.8)
  Gestational age at first visit (weeks) (SD)                11.9 (1.4)
  Years of formal education (years) (SD)                     15.1 (2.9)
  Haemoglobin level before 15 weeks' gestation (g/dL) (SD)   12.5 (1.1)
  Married/cohabiting (%)                                     3020 (97.3)
  Nulliparous (%)                                            2230 (71.8)
  Pre-eclampsia (%)                                          12 (0.4)
  Pyelonephritis (%)                                         9 (0.3)
  Any sexually transmitted infection (%)                     1 (0.0)
  Spontaneous initiation of labour (%)                       2127 (68.5)
  PPROM (\<37 weeks' gestation) (%)                          46 (1.5)
  Caesarean section (%)                                      1036 (33.4)
  Mother admitted to intensive care unit (%)                 9 (0.3)
  Infants                                                    
  NICU admission \>1 day (%)                                 160 (5.2)
  Preterm (\<37 weeks' gestation) (%)                        125 (4.0)
  Preterm and spontaneous onset of labour (%)                82 (2.6)
  Term LBW (\<2500 g; ≥37 weeks) (%)                         99 (3.2)
  Birth weight \>4.0 kg (%)                                  144 (4.7)
  Neonatal mortality (%)                                     4 (0.1)
  Male sex (%)                                               1534 (49.4)
  Exclusive breastfeeding at discharge (%)                   2698 (86.9)
  Mean (SD) weight (kg) (≥37 weeks' gestation)               3.2 (0.4)
  Mean (SD) length (cm) (≥37 weeks' gestation)               49.3 (1.9)
  Mean (SD) head circumference (cm) (≥37 weeks' gestation)   33.8 (1.3)

PPROM=preterm pre-labour rupture of membranes; NICU=neonatal intensive care unit; LBW=low birthweight.

![**Fig 2** Trajectories of gestational weight gain of 100 randomly selected normal weight healthy women with uncomplicated live singleton births](chel028538.f2_default){#f2}

We explored the variation in GWG among the sites; the variance within sites (59.6%) was six times higher than the variance between sites (9.6%). The all sites' SD for GWG ranged from 1.45 kg at 14-19^+6^ weeks' gestation to 1.61 kg at 34-40 weeks' gestation. Within five gestational age windows from 14 weeks to 40^+0^ weeks, representing 40 comparisons, 37 had standardised site differences (SSDs) ≤0.5 (as prespecified in the protocol) of the SD of all sites combined (fig 3[](#f3){ref-type="fig"}, table 2[](#tbl2){ref-type="table"}). The three comparisons that were higher than 0.5 SSD were from China, but the difference was \<0.5 at 14-18^+6^ weeks' gestation and at 34-40 weeks' gestation (0.34 and 0.21, respectively).

![**Fig 3** Standardised site difference (SSD) for gestational weight gain in the Fetal Growth Longitudinal Study of the INTERGROWTH-21^st^ Project. SSD calculated by (site mean of gestational weight gain at each gestational age interval minus all sites mean of gestational weight gain at the same gestational age interval)/all sites' SD of gestational weight gain at the same gestational age interval. SSD was adjusted at median gestational age for all sites at each gestational age interval](chel028538.f3_default){#f3}

###### 

All sites and individual site means (SD) for gestational weight gain (kg) of normal weight women

  Gestational age and Country   No of measures   Adjusted mean (SD) GWG (kg)   Standardised site difference (SSD)\*
  ----------------------------- ---------------- ----------------------------- --------------------------------------
  14-18^+6^ weeks                                                              
  Brazil                        252              1.84 (1.34)                   0.14
  China                         476              2.14 (1.28)                   0.34
  India                         441              1.36 (1.30)                   −0.20
  Kenya                         355              1.52 (1.65)                   −0.09
  Oman                          360              0.96 (1.53)                   −0.47
  UK                            408              1.83 (1.44)                   0.13
  USA                           221              1.79 (1.40)                   0.10
  Italy                         392              1.71 (1.29)                   0.05
  All                           2905             1.64 (1.45)                   0.00
  19-23^+6^ weeks                                                              
  Brazil                        252              2.62 (1.11)                   −0.16
  China                         485              4.00 (1.57)                   0.79
  India                         448              2.22 (1.33)                   −0.43
  Kenya                         356              2.57 (1.46)                   −0.20
  Oman                          366              2.73 (1.31)                   −0.08
  UK                            413              2.80 (1.26)                   −0.04
  USA                           211              2.84 (1.40)                   −0.01
  Italy                         384              2.75 (1.24)                   −0.07
  All                           2915             2.86 (1.46)                   0.00
  24-28^+6^ weeks                                                              
  Brazil                        251              2.81 (1.46)                   −0.04
  China                         448              3.77 (1.68)                   0.62
  India                         455              2.37 (1.40)                   −0.34
  Kenya                         360              2.48 (1.29)                   −0.26
  Oman                          370              2.91 (1.39)                   0.03
  UK                            412              2.81 (1.27)                   −0.04
  USA                           204              2.97 (1.30)                   0.07
  Italy                         375              2.75 (1.35)                   −0.08
  All                           2875             2.86 (1.47)                   0.00
  29-33^+6^ weeks                                                              
  Brazil                        261              2.53 (1.43)                   −0.04
  China                         545              3.41 (1.61)                   0.55
  India                         428              2.28 (1.48)                   −0.21
  Kenya                         355              2.18 (1.39)                   −0.27
  Oman                          363              2.43 (1.39)                   −0.11
  UK                            417              2.59 (1.23)                   0.00
  USA                           216              2.52 (1.73)                   −0.04
  Italy                         373              2.37 (1.35)                   −0.15
  All                           2958             2.59 (1.51)                   0.00
  34-40^+0^ weeks                                                              
  Brazil                        269              2.48 (1.57)                   −0.05
  China                         485              2.91 (1.40)                   0.22
  India                         406              2.19 (1.30)                   −0.23
  Kenya                         388              2.42 (2.41)                   −0.09
  Oman                          406              2.60 (1.36)                   0.02
  UK                            534              2.61 (1.26)                   0.03
  USA                           220              2.68 (2.14)                   0.07
  Italy                         370              2.55 (1.40)                   −0.01
  All                           3078             2.56 (1.61)                   0.00

\*Calculated by: (site mean of GWG−all sites mean of GWG at each gestational age interval)/all sites' SD of GWG. SSD adjusted at median gestational age for all sites at each gestational age interval with estimates from final regression model.

The mean GWGs were 1.64 kg, 2.86 kg, 2.86 kg, 2.59 kg, and 2.56 kg for the gestational age windows 14-18^+6^ weeks, 19-23^+6^ weeks, 24-28^+6^ weeks, 29-33^+6^ weeks, and 34-40^+0^ weeks, respectively (table 2[](#tbl2){ref-type="table"}). Of all the weight measurements, 71.7% (10 639/14 846) and 94.9% (14 085/14 846) fell within the expected 1 SD and 2 SD thresholds, respectively, which compares well with 68% and 95% theoretically expected under normality assumptions. On average, across all gestational ages, the absolute magnitude of differences between the observed (empirical) and smoothed centiles was 0.18 kg for the median, 0.37 kg for the 3rd centile, and 0.06 kg for the 97th centile (fig 4[](#f4){ref-type="fig"}).

![**Fig 4** Fitted 3rd (bottom dashed line), 50th (middle dashed line), and 97th (top dashed line) smoothed centile curves for gestational weight gain among normal weight women. Large blue circles show empirical values for each week of gestation, and small grey circles show actual observations](chel028538.f4_default_default){#f4}

Table 3[](#tbl3){ref-type="table"} provides the values of the smoothed week specific GWG according to gestational age of selected centiles (that is, 3rd, 10th, 25th, 50th, 75th, 90th, and 97th), which are shown graphically in figure 5[](#f5){ref-type="fig"}. We have also provided the corresponding equations for the mean and SD from the multilevel regression model (table 4[](#tbl4){ref-type="table"}), allowing for calculation of any desired centiles according to gestational age in exact weeks. For example, centiles can be calculated as mean ±z×SD, where z is −1.88, −1.645, −1.28, 0, 1.28, 1.645, and 1.88 for the 3rd, 5th, 10th, 50th, 90th, 95th, and 97th centiles, respectively.

###### 

Smoothed centiles for gestational weight gain (GWG) for women of normal weight (BMI 18.50-24.99) according to gestational age

  Gestational age (weeks)   No of measures   Centiles for GWG (kg)                                           
  ------------------------- ---------------- ----------------------- ------- ------- ------- ------- ------- -------
  14                        260              −2.34                   −1.73   −1.07   −0.25   0.65    1.54    2.50
  15                        473              −1.77                   −1.14   −0.45   0.39    1.32    2.24    3.23
  16                        705              −1.26                   −0.60   0.13    1.01    1.99    2.95    3.98
  17                        851              −0.80                   −0.09   0.67    1.61    2.64    3.65    4.75
  18                        639              −0.37                   0.38    1.19    2.19    3.29    4.36    5.53
  19                        324              0.03                    0.82    1.69    2.75    3.92    5.07    6.31
  20                        532              0.41                    1.25    2.17    3.30    4.55    5.78    7.11
  21                        627              0.77                    1.66    2.64    3.84    5.17    6.49    7.91
  22                        715              1.11                    2.05    3.10    4.37    5.79    7.19    8.72
  23                        717              1.45                    2.44    3.54    4.90    6.41    7.90    9.52
  24                        399              1.77                    2.82    3.98    5.42    7.02    8.61    10.34
  25                        500              2.09                    3.19    4.42    5.94    7.63    9.31    11.15
  26                        599              2.40                    3.56    4.85    6.45    8.24    10.02   11.97
  27                        675              2.71                    3.93    5.28    6.96    8.85    10.73   12.79
  28                        702              3.02                    4.29    5.71    7.47    9.45    11.43   13.61
  29                        493              3.33                    4.65    6.14    7.98    10.06   12.14   14.44
  30                        526              3.63                    5.01    6.56    8.49    10.67   12.86   15.27
  31                        533              3.94                    5.37    6.99    9.00    11.28   13.57   16.10
  32                        691              4.24                    5.73    7.41    9.52    11.89   14.29   16.94
  33                        715              4.55                    6.10    7.84    10.03   12.51   15.01   17.78
  34                        498              4.85                    6.46    8.27    10.55   13.12   15.73   18.62
  35                        533              5.16                    6.82    8.70    11.06   13.74   16.46   19.47
  36                        514              5.47                    7.19    9.14    11.58   14.37   17.19   20.32
  37                        858              5.78                    7.56    9.57    12.11   14.99   17.92   21.18
  38                        402              6.10                    7.93    10.01   12.63   15.62   18.66   22.04
  39                        230              6.41                    8.30    10.45   13.16   16.25   19.40   22.91
  40                        82               6.73                    8.68    10.89   13.69   16.89   20.15   23.79
  Total No of measures      14 793           ---                     ---     ---     ---     ---     ---     ---

![**Fig 5** Smoothed centile curves at 3rd, 10th, 50th, 90th, and 97th centiles for gestational weight gain among healthy normal weight women with uncomplicated live singleton births](chel028538.f5_default_default){#f5}

###### 

Equations for estimating mean and standard deviation (SD) of gestational weight gain in normal weight women according to exact gestational age (weeks)\*

  Estimate          Regression equation
  ----------------- --------------------------------------------------------
  Mean; log (GWG)   1.382972−56.14743×GA^−2^+0.2787683×GA^0.5^
  SD; log (GWG)     0.2501993731+142.4297879×GA^−2^−61.45345×GA^−2^×LN(GA)

GA=exact gestational age in weeks.

\*All logarithms are natural logarithms. Using equations of mean and SD one can easily compute any desired centiles using relation *P*^th^ centile=mean+*K*SD where *K* is normal equivalent deviate (z score) corresponding to particular centile---for example, *K*=1.88 for 97th centile and −1.88 for 3rd centile, and SDs in this equation are predicted estimates from the regression analysis. For example to calculate gestational weight gain at 34 weeks;

C50 for GWG=exp((1.382972−56.14743×34^−2^+0.2787683×34^0.5^)+(0×(0.2501993731+142.4297879×34^−2^ − 61.45345\*34^−2^\*LN(34)))) -- 8.75

C3 for GWG=exp((1.382972−56.14743×34^−2^+0.2787683×34^0.5^)+(−1.88×(0.2501993731+142.4297879×34^−2^ − 61.45345\*34^−2^×LN(34)))) -- 8.75

C97 for GWG=exp((1.382972− 56.14743×34^−2^+0.2787683×34^0.5^)+(1.88×(0.2501993731+142.4297879×34^−2^ −61.45345\*34^−2^×LN(34)))) -- 8.75

The sensitivity analyses performed to assess the impact of potential misclassification of BMI status resulted in 30% (932/3097) of women being excluded from the normal weight group and 53% (n=639/1216) of women being added from the overweight group to form a reclassified group of normal weight women (n=2804 women, 17 579 observations). The resultant centile values were remarkably similar and indistinguishable when we superimposed them on the normal weight GWG chart. Sensitivity results when we excluded women with caesarean sections had minimal effect compared with results using all the data (data not shown).

Tables containing the mean and SD, centile values, and z scores by gestational age, expressed in completed weeks' gestation (as recommended by WHO ICD10[@ref44]), and printable charts are available at [www.intergrowth21.org](http://www.intergrowth21.org).

Discussion
==========

Principal findings
------------------

Despite the range of cultures, behaviours, clinical practices, and traditions, which can strongly influence gestational weight gain (GWG), we observed strikingly similar patterns of weight gain in the populations studied, reflecting their overall good health and living conditions, nutritional status, and access to adequate standardised healthcare. The proportion of total variance explained by population differences was \<10% of the total variance. This finding indicates not only that separate GWG charts for women from different ethnic/racial groups are not required, as is the case for growth standards from early pregnancy to 5 years of age,[@ref24] [@ref26] [@ref27] but that the observed differences by race/ethnicity reported in some studies[@ref45] [@ref46] [@ref47] [@ref48] are more likely caused by socioeconomic, medical, cultural, and nutritional factors than true biological differences in the process of nutrient absorption or fat deposition among healthy women. We adopted a prescriptive approach, employed highly trained anthropometrists to measure maternal weight prospectively in duplicate, and used uniform and standardised measurement equipment and protocols. We used the patterns in weight gain in women with a normal BMI in early pregnancy to produce international standards, using statistical techniques that account for repeated measurements within women at one site and between women across sites. We developed a standard, as well as the accompanying centile chart and simple formulae, to allow any desired centiles or z scores to be calculated. These tools complement the already published fetal growth, neonatal size, and postnatal growth of preterm infant standards from the INTERGROWTH-21^st^ Project.[@ref26] [@ref27] [@ref28]

Comparison with other studies
-----------------------------

Comparisons with previous studies on this subject are difficult because of wide variations in study designs, methods, and populations selected. In particular, some studies based GWG on maternally recalled weight before pregnancy, while we measured weight using standardised methods at the first trimester visit. Nonetheless, the weight gain at term of women in the Fetal Growth Longitudinal Study (13.7 kg) was comparable with the range recommended in 2009 by the Institute of Medicine/National Research Council for normal weight women (11.5-16.0 kg) and optimal GWG reported for a multiethnic Singaporean population (13.7 kg), but about 2-3 kg less than that for low risk urban populations in Leuven, Belgium (15.9 kg) and Pittsburgh, USA (16.4 kg).[@ref1] [@ref16] [@ref21] [@ref22] Other prospective longitudinal studies of healthy women in Mexico City, urban regions of Argentina, and rural Malawi reported GWG at term of 12.1 kg, 10.7 kg, and 3.7-6.4 kg,[@ref49] [@ref50] [@ref51] respectively, and large cross sectional studies of low risk Japanese women, well nourished women in Switzerland, and Swedish birth registry records have reported singleton term GWG of 10.0 kg, 15.5 kg, and 13.8 kg, respectively.[@ref17] [@ref47] [@ref52] All these studies were based on country specific populations and used various classifications of BMI status. Furthermore, most of them relied on recalled or routinely recorded weight measurements from medical records or weight data from large population databases with questionable measurement sources, validity, and reliability.

Strengths and limitations of study
----------------------------------

We recognise that our study has some limitations. As the first weight measurement was taken between 9 and 13^+6^ weeks' gestation, the BMI classification of women as normal weight was not based on a value from before pregnancy. The results of the post hoc sensitivity analysis, however, were reassuring, and we believe that the effect of any possible misclassification is therefore small. Measurements before pregnancy are seldom available in clinical practice or research studies, especially in low risk women.[@ref53] [@ref54] Recruitment of women who intend to conceive is also challenging and might be culturally unacceptable in some populations, which would introduce selection bias; this could explain why there are few studies with measured pre-pregnancy weight, which should ideally be used to construct GWG references or standards. Consequently, clinicians and researchers have often relied on self reported pre-pregnancy weight to estimate BMI and monitor GWG,[@ref55] despite the considerable limitations of error and recall bias.[@ref56] Another limitation is that it was not possible to infer the most appropriate GWG pattern for women who are underweight or obese as our population consisted only of healthy women with a BMI range of 18.5-\<30. Underweight women are at increased risk for several adverse outcomes, including fetal growth restriction, so adequate GWG is especially important for this group.[@ref5] [@ref57] [@ref58] [@ref59] Conversely, the growing problem of maternal obesity throughout the world has led to great interest in whether limiting GWG can reduce the risk of the associated adverse outcomes.[@ref1] It could be argued that the sample size is relatively small compared with epidemiological studies that have reported data from large populations---for example, the Danish National Birth Cohort of more than 60 000 women.[@ref60] It is always difficult to reach a balance between sample size and data quality, particularly when larger samples require the use of routinely collected clinical information. We decided when designing the study that it was more important to have a sufficiently large sample, collected prospectively in a scientifically robust manner, with standardised methods, quality control, and equipment, than a larger sample using data that have been routinely collected with less rigour and precision.

Policy implications
-------------------

Our results have several practical implications. Firstly, we are aware that in some settings, such as the UK, routine weight monitoring is not recommended.[@ref15] In most countries worldwide and in particular those with large populations at risk of under-nutrition, however, weight monitoring at antenatal visits is common practice. Our aim was to contribute to the standardisation of weight monitoring and the more systematic use of the data obtained. Overall, we suggest that the standards (as part of first level nutritional screening) can be used to alert clinicians to deviations in weight, triggering clinical inquiries as to whether such deviations are associated with complications related to pregnancy, medical conditions, or eating disorders. We would discourage clinicians, however, from telling women that deviations are due to pregnancy complications or recommending immediate behaviour changes as our data do not provide sufficient evidence for the standards to be interpreted in this way. Secondly, we believe that consideration should be given to referring women who are underweight before pregnancy for nutritional advice and treatment if necessary and that it is safe to suggest that during pregnancy such women should have GWG at least compatible with those of normal weight women. Finally, our data cannot be used to make recommendations to underweight, overweight, or obese women beyond those already provided by NICE.[@ref61]

Conclusions
-----------

In summary, we have described patterns of GWG among normal weight women that are compatible with desirable healthy pregnancy outcomes, which provide a basis to guide clinical recommendations on weight gain. To facilitate the use of such recommendations in clinical settings, epidemiological studies with data on important long term maternal and childhood outcomes are needed to identify optimal centile (that is, outcome based cut off points) categories associated with the best health outcomes. Towards that end, the INTERGROWTH-21^st^ Project is currently collecting one and two year follow-up data, including postpartum maternal weight patterns. We anticipate that the publication of this GWG standard will prompt debate among epidemiologists, nutritionists, obstetricians, and midwives about what the optimal thresholds should be. We believe that this standard is more robust than any other available charts and adds to the set of international standards from the INTERGROWTH-21^st^ Project, which aims to improve pregnancy care practices and outcomes by establishing benchmarks against which all women, their unborn babies, and newborns can be compared.[@ref26] [@ref27] [@ref28]

### What is already known on this topic

1.  Guidelines and charts for gestational weight gain (GWG) that are currently in use around the world were derived from country specific studies

2.  A recent systematic review assessing the quality of these studies has shown considerable heterogeneity in methods, in particular in terms of sample selection, study design, and methods of data collection and statistical analysis

3.  This could explain the variation in recommendations and the lack of consensus regarding what constitutes adequate weight gain

### What this study adds

1.  This multi-country study of GWG adopted a prescriptive and highly standardised approach to describing the GWG patterns of normal weight women at low risk of adverse maternal and perinatal outcomes

2.  The generated standards could be used to alert clinicians to deviations in weight, which should then initiate a series of questions to determine whether the changes are associated with complications related to pregnancy, medical conditions, or eating disorders

3.  These standards are more scientifically robust than other published charts and add to the set of international standards from the INTERGROWTH-21^st^ Project
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